|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
19.22(B) |
Last
Volume: |
618,418 |
Avg
Vol: |
1,171,182 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,760 |
18,097 |
18,097 |
100,860 |
Total Sell Value |
$246,400 |
$2,309,019 |
$2,309,019 |
$14,306,288 |
Total People Sold |
1 |
4 |
4 |
6 |
Total Sell Transactions |
1 |
7 |
7 |
21 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wilensky Gail R |
Director |
|
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
26,604 |
|
- |
|
Gregg Vicky B |
Director |
|
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
10,213 |
|
- |
|
Torley Helen |
Director |
|
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
1,644 |
|
- |
|
Stanzione Daniel |
Director |
|
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
36,319 |
|
- |
|
Main Timothy L |
Director |
|
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
16,335 |
|
- |
|
Cohen Jon R |
SVP & Group Exec. Diag. Sol. |
|
2018-03-08 |
4 |
AS |
$104.09 |
$8,717,937 |
D/D |
(83,669) |
31,757 |
|
- |
|
Cohen Jon R |
SVP & Group Exec. Diag. Sol. |
|
2018-03-08 |
4 |
OE |
$66.51 |
$2,589,101 |
D/D |
38,928 |
115,426 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2018-03-05 |
4 |
AS |
$101.00 |
$517,322 |
D/D |
(5,122) |
37,067 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2018-03-05 |
4 |
AS |
$101.00 |
$561,156 |
D/D |
(5,556) |
67,941 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2018-03-05 |
4 |
AS |
$101.00 |
$416,928 |
D/D |
(4,128) |
39,771 |
|
- |
|
Klug Robert A |
VP, Corporate Controller |
|
2018-03-02 |
4 |
D |
$101.00 |
$43,329 |
D/D |
(429) |
4,803 |
|
- |
|
Klug Robert A |
VP, Corporate Controller |
|
2018-03-02 |
4 |
A |
$101.00 |
$137,865 |
D/D |
1,365 |
5,206 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2018-03-02 |
4 |
D |
$101.00 |
$683,164 |
D/D |
(6,764) |
42,189 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2018-03-02 |
4 |
A |
$101.00 |
$1,200,486 |
D/D |
11,886 |
48,909 |
|
- |
|
Rusckowski Stephen H |
Chairman, President and CEO |
|
2018-03-02 |
4 |
D |
$101.00 |
$2,366,228 |
D/D |
(23,428) |
191,069 |
|
- |
|
Rusckowski Stephen H |
Chairman, President and CEO |
|
2018-03-02 |
4 |
A |
$101.00 |
$4,422,689 |
D/D |
43,789 |
214,497 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2018-03-02 |
4 |
D |
$101.00 |
$653,571 |
D/D |
(6,471) |
58,200 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2018-03-02 |
4 |
A |
$101.00 |
$1,326,837 |
D/D |
13,137 |
64,671 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2018-03-02 |
4 |
D |
$101.00 |
$544,693 |
D/D |
(5,393) |
73,497 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2018-03-02 |
4 |
A |
$101.00 |
$1,105,849 |
D/D |
10,949 |
78,890 |
|
- |
|
Cunningham Everett |
SVP, Commercial |
|
2018-03-02 |
4 |
D |
$101.00 |
$544,693 |
D/D |
(5,393) |
45,916 |
|
- |
|
Cunningham Everett |
SVP, Commercial |
|
2018-03-02 |
4 |
A |
$101.00 |
$1,105,849 |
D/D |
10,949 |
51,266 |
|
- |
|
Cohen Jon R |
SVP & Group Exec. Diag. Sol. |
|
2018-03-02 |
4 |
D |
$101.00 |
$544,693 |
D/D |
(5,393) |
76,498 |
|
- |
|
Cohen Jon R |
SVP & Group Exec. Diag. Sol. |
|
2018-03-02 |
4 |
A |
$101.00 |
$1,105,849 |
D/D |
10,949 |
81,891 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2018-03-02 |
4 |
D |
$101.00 |
$404,606 |
D/D |
(4,006) |
43,899 |
|
- |
|
787 Records found
|
|
Page 19 of 32 |
|
|